logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Drug Design and Discovery in Alzheimer's Disease by Choudhary, Muhammad Iqbal; Rahman, Atta-ur ISBN 9780128039595, 9780128039601, 0128039590, 0128039604

  • SKU: EBN-5432994
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) Drug Design and Discovery in Alzheimer's Disease after payment.
Authors:Choudhary, Muhammad Iqbal; Rahman, Atta-ur
Pages:784 pages.
Year:2014
Editon:1
Publisher:Elsevier, Bentham Science Publishers
Language:english
File Size:56.52 MB
Format:pdf
ISBNS:9780128039595, 9780128039601, 0128039590, 0128039604
Categories: Ebooks

Product desciption

(Ebook) Drug Design and Discovery in Alzheimer's Disease by Choudhary, Muhammad Iqbal; Rahman, Atta-ur ISBN 9780128039595, 9780128039601, 0128039590, 0128039604

Drug Design and Discovery in Alzheimer’s Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of β-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery.Edited and written by leading experts in Alzheimer’s disease (AD) and other neurodegenerative disease drug developmentDescribes existing drugs for AD and current molecular understanding of the conditionReviews recent advances in the field, including coverage of cholinesterases, BACE-1, and other drug development targets
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products